The National Comprehensive Cancer Network® (NCCN) recently updated its NCCN Clinical Practice Guidelines in Oncology® to include stereotactic body radiation therapy (SBRT) as a treatment option for prostate cancer.
An alliance of 23 of the world’s leading cancer centers, the NCCN is an institution that works to develop treatment guidelines for many cancers, and is also dedicated to supporting research that improves the quality of cancer care.
The addition of SBRT as a recommended treatment option for prostate cancer is a milestone, as it demonstrates acceptance and support of SBRT from a leading, world-renown coalition of cancer centers. SBRT for prostate cancer involves five or fewer treatment sessions, minimizing disruption to men’s normal routines and lifestyles.
Read more about the NCCN and their guidelines here.
According to the American Cancer Society, prostate cancer is the second leading cause of cancer-related deaths among American men, but the numbers are decreasing thanks to improved detection methods and treatments, such as the CyberKnife Radiosurgery at the CyberKnife Center of Miami. With the CyberKnife, we can safely and effectively target the cancerous growth with precision and minimal side effects.